Demetrius Araujo

Dr. Demetrius Araujo

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2017 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SDSarah S. Damasceno
Sarah S. Damasceno
BDBruna B. Dantas
Bruna B. Dantas
Jaime Ribeiro-FilhoJaime Ribeiro-Filho
Jaime Ribeiro-Filho
DADemetrius Araujo
Demetrius Araujo
JCJosé Galberto M. da Costa
José Galberto M. da Costa
The antioxidant properties of caffeic and ferulic acids in biological systems have been extensively demonstrated. As antioxidants, these compounds prevent the production of reactive oxygen species (ROS), which cause cell lesions that are associated with the development of several diseases, including cancer. Recent findings suggest that the chemoprotective action of these phenolic acids occurs through the following mechanisms: regulation of gene expression, chelation and / or reduction of transition metals, formation of covalent adducts and direct toxicity. The biological efficacy of these promising chemoprotective agents is strongly related with their chemical structure. Therefore, in this study, we discuss the structural characteristics of ferulic and caffeic acids that are responsible for their biological activities, as well as the mechanisms of action involved with the anti-cancer activity. Several reports indicated that the antioxidant effect of these phenylpropanoids results from reactions with free radicals with formation of stable products in the cells. The chelating effect of these compounds was also reported as an important protective mechanism against oxidative. Finally, the lipophilicity of these agents facilitates their entry into the cells, and thus, contributes to the anticancer activity.

1 July 2006 in Neuroscience Letters
Verified
Journal Article
Closed access
Damiao Pergentino de SousaDamiao Pergentino de Sousa
Damiao Pergentino de Sousa
JGJUAN GONÇALVES
JUAN GONÇALVES
LQLucindo Quintans-Junior
Lucindo Quintans-Junior
JCJader Cruz
Jader Cruz
DADemetrius Araujo
Demetrius Araujo
RAReinaldo Nóbrega de Almeida
Reinaldo Nóbrega de Almeida

12 June 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
OMOsvaldo Marinotti
Osvaldo Marinotti
GCGustavo C. Cerqueira
Gustavo C. Cerqueira
LALuiz G P de Almeida
Luiz G P de Almeida
MFMaria Inês Tiraboschi Ferro
Maria Inês Tiraboschi Ferro
ELElgion Lucio da Silva Loreto
Elgion Lucio da Silva Loreto
AVAna Tereza Ribeiro de Vasconcelos
Ana Tereza Ribeiro de Vasconcelos
Anopheles darlingi is the principal neotropical malaria vector, responsible for more than a million cases of malaria per year on the American continent. Anopheles darlingi diverged from the African and Asian malaria vectors ∼100 million years ago (mya) and successfully adapted to the New World environment. Here we present an annotated reference A. darlingi genome, sequenced from a wild population of males and females collected in the Brazilian Amazon. A total of 10 481 predicted protein-coding genes were annotated, 72% of which have their closest counterpart in Anopheles gambiae and 21% have highest similarity with other mosquito species. In spite of a long period of divergent evolution, conserved gene synteny was observed between A. darlingi and A. gambiae . More than 10 million single nucleotide polymorphisms and short indels with potential use as genetic markers were identified. Transposable elements correspond to 2.3% of the A. darlingi genome. Genes associated with hematophagy, immunity and insecticide resistance, directly involved in vector–human and vector–parasite interactions, were identified and discussed. This study represents the first effort to sequence the genome of a neotropical malaria vector, and opens a new window through which we can contemplate the evolutionary history of anopheline mosquitoes. It also provides valuable information that may lead to novel strategies to reduce malaria transmission on the South American continent. The A. darlingi genome is accessible at www.labinfo.lncc.br/index.php/anopheles-darlingi .

1 January 2008 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
JGJUAN GONÇALVES
JUAN GONÇALVES
FOFernando de Sousa Oliveira
Fernando de Sousa Oliveira
RBRubens Batista Benedito
Rubens Batista Benedito
Damiao Pergentino de SousaDamiao Pergentino de Sousa
Damiao Pergentino de Sousa
RAReinaldo Nóbrega de Almeida
Reinaldo Nóbrega de Almeida
DADemetrius Araujo
Demetrius Araujo
(−)-Carvone is a monoterpene ketone that is the main active component of Mentha plant species like Mentha spicata. This study aimed to investigate the antinociceptive activity of (−)-carvone using different experimental models of pain and to investigate whether such effects might be involved in the nervous excitability elicited by others monoterpenes. In the acetic acid-induced writhing test, we observed that (−)-carvone-treated mice exhibited a significant decrease in the number of writhes when 100 and 200 mg/kg was administered. It was also demonstrated that (−)-carvone inhibited the licking response of the injected paw when 100 and 200 mg/kg was administered (i.p.) to mice in the first and second phases of the formalin test. Since naloxone (5 mg/kg, s.c.), an opioid antagonist, showed no influence on the antinociceptive action of (−)-carvone (100 mg/kg), this suggested nonparticipation of the opioid system in the modulation of pain induced by (−)-carvone. Such results were unlikely to be provoked by motor abnormality, since (−)-carvone-treated mice did not exhibit any performance alteration on the Rota-rod apparatus. Because the antinociceptive effects could be associated with neuronal excitability inhibition, we performed the single sucrose gap technique and observed that (−)-carvone (10 mM) was able to reduce the excitability of the isolated sciatic nerve through a diminution of the compound action potential amplitude by about 50% from control recordings. We conclude that (−)-carvone has antinociceptive activity associated with decreased peripheral nerve excitability.

1 October 2012 in Toxicology in Vitro
Verified
Journal Article
Closed access
GFGlaucia V. Faheina-Martins
Glaucia V. Faheina-Martins
ASAlethéia Lacerda da Silveira
Alethéia Lacerda da Silveira
BCBruno C. Cavalcanti
Bruno C. Cavalcanti
MRMárcio V. Ramos
Márcio V. Ramos
MMManoel O. Moraes
Manoel O. Moraes
DADemetrius Araujo
Demetrius Araujo

1 October 2010 in European Journal of Pharmacology
Verified
Journal Article
Closed access
JGJUAN GONÇALVES
JUAN GONÇALVES
AAAron de Miranda H. Alves
Aron de Miranda H. Alves
AAAnna Erika V. de Araújo
Anna Erika V. de Araújo
JCJader Cruz
Jader Cruz
DADemetrius Araujo
Demetrius Araujo